 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
CVGR is an emerging name in the huge Contract Research Market,as more and more drug and bio-tech companies are outscourcing their clinical testing.The story here is an incredible management team led by the CEO,Bruce Lamont who came out of Merck.A new addition is Dr.Ken Bowers,recently head of Clinical Research at MRK.This is a people business,and these people are well known and well respected.Last year they did $10.4mm in revenues and earned $.05,thsis year is estimnated to be $20mm ans $.20,and next year could be explosive because of a new Ineractive Voice Recognition sysyte,Virtual Housecall,whcich will help,patients,drug companies,HMO's employers,keep their costs down or their sales up.This is a stock to monitor.They just announced a deal with r.r.donnelly(DNY) who will partner with them in going after the managed care giants.
| ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |